RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
RYBREVANT 350 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Pending
Register Number
1211594001
Prescription Type
Uso Hospitalario
Authorization Date
Jan 12, 2022
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1211594001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
AMIVANTAMABActive
Quantity: 350 mg
Name: AMIVANTAMAB
ATC CLASSIFICATION (3)
L01F
L01FX
L01FX18